Bentong Yu

437 total citations
12 papers, 318 citations indexed

About

Bentong Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bentong Yu has authored 12 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Bentong Yu's work include RNA modifications and cancer (5 papers), Genomics and Chromatin Dynamics (2 papers) and Ferroptosis and cancer prognosis (2 papers). Bentong Yu is often cited by papers focused on RNA modifications and cancer (5 papers), Genomics and Chromatin Dynamics (2 papers) and Ferroptosis and cancer prognosis (2 papers). Bentong Yu collaborates with scholars based in China. Bentong Yu's co-authors include Jingtao Zhang, Yaxing Shen, Lijie Wang, Weiyu Shen, Chaoqun Yu, Lijuan Liu, Lei Zeng, Kaishun Hu, Xiaobin Lv and Chun Cheng and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Cell Death and Disease.

In The Last Decade

Bentong Yu

12 papers receiving 317 citations

Peers

Bentong Yu
Chiyuan Piao China
Shuai Leng China
Guobin Tan China
Ke Zheng China
Sha Shi China
Xiaobin Lv China
Bingluo Zhou China
Shentong Yu China
Chiyuan Piao China
Bentong Yu
Citations per year, relative to Bentong Yu Bentong Yu (= 1×) peers Chiyuan Piao

Countries citing papers authored by Bentong Yu

Since Specialization
Citations

This map shows the geographic impact of Bentong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bentong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bentong Yu more than expected).

Fields of papers citing papers by Bentong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bentong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bentong Yu. The network helps show where Bentong Yu may publish in the future.

Co-authorship network of co-authors of Bentong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Bentong Yu. A scholar is included among the top collaborators of Bentong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bentong Yu. Bentong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xu, Chuan, Mingshan Liu, Yang Li, et al.. (2025). The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma. Discover Oncology. 16(1). 270–270. 1 indexed citations
2.
Yu, Bentong, et al.. (2024). Phosphorylation of LZTS2 by PLK1 activates the Wnt pathway. Cellular Signalling. 120. 111226–111226. 3 indexed citations
3.
Shen, Yaxing, Jingtao Zhang, Lijie Wang, et al.. (2022). CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Molecular Cancer. 21(1). 145–145. 104 indexed citations
4.
Zhang, Qin, et al.. (2021). The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620. Frontiers in Oncology. 11. 669518–669518. 28 indexed citations
5.
Sang, Yonghua, et al.. (2021). AMPK activation by ASP4132 inhibits non-small cell lung cancer cell growth. Cell Death and Disease. 12(4). 365–365. 38 indexed citations
6.
7.
He, Yiming, Mingxi Gan, Yanan Wang, et al.. (2021). EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer. Cell Death and Disease. 12(5). 430–430. 10 indexed citations
8.
Liu, Xiaoming, et al.. (2021). CRKL is a critical target of Hh‐GLI2 pathway in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 25(13). 6280–6288. 4 indexed citations
9.
Zhang, Jingtao, et al.. (2019). Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma. Medical Science Monitor. 25. 4264–4272. 12 indexed citations
10.
Song, Baoquan, Hairui Zhang, Lei Jiang, et al.. (2015). Down-regulation of lipocalin 2 suppresses the growth of human lung adenocarcinoma through oxidative stress involving Nrf2/HO-1 signaling. Acta Biochimica et Biophysica Sinica. 47(10). 805–814. 23 indexed citations
11.
Lv, Xiaobin, Lijuan Liu, Chun Cheng, et al.. (2015). SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer. Scientific Reports. 5(1). 17940–17940. 72 indexed citations
12.
Yu, Bentong, et al.. (2013). [Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma].. PubMed. 48(5). 635–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiyuan Piao Breakdown of academic impact, for papers by Shuai Leng Breakdown of academic impact, for papers by Guobin Tan Breakdown of academic impact, for papers by Ke Zheng Breakdown of academic impact, for papers by Sha Shi Breakdown of academic impact, for papers by Xiaobin Lv Breakdown of academic impact, for papers by Bingluo Zhou Breakdown of academic impact, for papers by Shentong Yu
Rankless by CCL
2026